Tag: KEYNOTE-598

No long-term benefit of adding ipilimumab to pembrolizumab in metastatic NSCLC

Presented By
Dr Delvys Rodriguez-Abreu, Universidad de Las Palmas de Gran Canaria, Spain
Trial
Phase 3, KEYNOTE-598
Conference
ELCC 2022
Type
Peer-reviewed article

25 May 2022 12:38

ELCC 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ELCC 2022

19 April 2022 10:43
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com